Portfolio company Volpara Health Technologies agreed to be acquired by Lunit for approximately US$193M; the deal completed in May 2024.
Volpara Health provides advanced analytics and software solutions for breast cancer screening, focusing on improving the accuracy and efficiency of mammography
Volpara Health provides advanced analytics and software solutions for breast cancer screening, focusing on improving the accuracy and efficiency of mammography.